123 related articles for article (PubMed ID: 38522768)
1. Efficacy and Safety of Postoperative Adjuvant Radiation Therapy in Resected Nasal Cavity and Paranasal Sinus Mucosal Melanoma: A Combined Analysis.
Lian B; Yang Y; Zheng B; Si L; Zhou L; Chi Z; Mao L; Wang X; Li S; Li J; Wang L; Guo J; Cui C
Int J Radiat Oncol Biol Phys; 2024 Mar; ():. PubMed ID: 38522768
[TBL] [Abstract][Full Text] [Related]
2. Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial.
Long GV; Luke JJ; Khattak MA; de la Cruz Merino L; Del Vecchio M; Rutkowski P; Spagnolo F; Mackiewicz J; Chiarion-Sileni V; Kirkwood JM; Robert C; Grob JJ; de Galitiis F; Schadendorf D; Carlino MS; Mohr P; Dummer R; Gershenwald JE; Yoon CH; Wu XL; Fukunaga-Kalabis M; Krepler C; Eggermont AMM; Ascierto PA;
Lancet Oncol; 2022 Nov; 23(11):1378-1388. PubMed ID: 36265502
[TBL] [Abstract][Full Text] [Related]
3. Failure patterns and prognostic factors of patients with primary mucosal melanoma of the nasal cavity and paranasal sinuses.
Liu ZP; Luo JW; Xu GZ; Gao L; Yi JL; Huang XD; Qu Y; Wang K; Zhang SP; Xiao JP
Acta Otolaryngol; 2017 Oct; 137(10):1115-1120. PubMed ID: 28767022
[TBL] [Abstract][Full Text] [Related]
4. Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses.
Combs SE; Konkel S; Thilmann C; Debus J; Schulz-Ertner D
Strahlenther Onkol; 2007 Feb; 183(2):63-8. PubMed ID: 17294109
[TBL] [Abstract][Full Text] [Related]
5. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma.
McLean N; Tighiouart M; Muller S
Oral Oncol; 2008 Nov; 44(11):1039-46. PubMed ID: 18396446
[TBL] [Abstract][Full Text] [Related]
6. Impact of adjuvant therapy on survival for sinonasal mucosal melanoma.
Lai Y; Meng X; Liu Q; Lu H; Guo L; Wang S; Wang D
Acta Otolaryngol; 2020 Jan; 140(1):79-84. PubMed ID: 31755795
[No Abstract] [Full Text] [Related]
7. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Eggermont AMM; Blank CU; Mandalà M; Long GV; Atkinson VG; Dalle S; Haydon AM; Meshcheryakov A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; van Akkooi ACJ; Krepler C; Ibrahim N; Marreaud S; Kicinski M; Suciu S; Robert C;
Lancet Oncol; 2021 May; 22(5):643-654. PubMed ID: 33857412
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses.
Zenda S; Akimoto T; Mizumoto M; Hayashi R; Arahira S; Okumura T; Sakurai H
Radiother Oncol; 2016 Feb; 118(2):267-71. PubMed ID: 26547102
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of endoscopic surgery and traditional open resection in mucosal melanoma of the nasal cavity and paranasal sinus.
Yin G; Guo W; Chen X; Huang Z
Melanoma Res; 2019 Feb; 29(1):47-52. PubMed ID: 30256270
[TBL] [Abstract][Full Text] [Related]
10. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Attard G; Murphy L; Clarke NW; Cross W; Jones RJ; Parker CC; Gillessen S; Cook A; Brawley C; Amos CL; Atako N; Pugh C; Buckner M; Chowdhury S; Malik Z; Russell JM; Gilson C; Rush H; Bowen J; Lydon A; Pedley I; O'Sullivan JM; Birtle A; Gale J; Srihari N; Thomas C; Tanguay J; Wagstaff J; Das P; Gray E; Alzoueb M; Parikh O; Robinson A; Syndikus I; Wylie J; Zarkar A; Thalmann G; de Bono JS; Dearnaley DP; Mason MD; Gilbert D; Langley RE; Millman R; Matheson D; Sydes MR; Brown LC; Parmar MKB; James ND;
Lancet; 2022 Jan; 399(10323):447-460. PubMed ID: 34953525
[TBL] [Abstract][Full Text] [Related]
11. Single-center retrospective series of fourteen patients with mucosal melanoma of the nasal cavity and paranasal sinuses.
Letievant JC; Poupart M; Ambrun A; Colin C; Pignat JC
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Dec; 133(6):387-391. PubMed ID: 27502822
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and prognosis of primary nasal mucosal melanoma--a report of 44 cases].
Peng RQ; Wu GH; Chen WK; Ding Y; Ma J; Zhang NH; Su YS; Zhang XS
Ai Zheng; 2006 Oct; 25(10):1284-6. PubMed ID: 17059777
[TBL] [Abstract][Full Text] [Related]
13. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
Amit M; Tam S; Abdelmeguid AS; Kupferman ME; Su SY; Raza SM; DeMonte F; Hanna EY
Ann Surg Oncol; 2018 Jun; 25(6):1723-1729. PubMed ID: 29626308
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Livingstone E; Zimmer L; Hassel JC; Fluck M; Eigentler TK; Loquai C; Haferkamp S; Gutzmer R; Meier F; Mohr P; Hauschild A; Schilling B; Menzer C; Kiecker F; Dippel E; Roesch A; Ziemer M; Conrad B; Körner S; Windemuth-Kieselbach C; Schwarz L; Garbe C; Becker JC; Schadendorf D;
Lancet; 2022 Oct; 400(10358):1117-1129. PubMed ID: 36099927
[TBL] [Abstract][Full Text] [Related]
16. Malignant tumors of the nasal cavity and paranasal sinuses.
Katz TS; Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Villaret DB
Head Neck; 2002 Sep; 24(9):821-9. PubMed ID: 12211046
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
18. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
20. [Management and prognosis of patients with squamous cell carcinomas of the nasal cavity and the paranasal sinuses].
Pickhard A; Durst F; Staudenmaier R; Reiter R
Laryngorhinootologie; 2012 Oct; 91(10):627-32. PubMed ID: 22930278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
